Journal
ACTA PAEDIATRICA
Volume 111, Issue 3, Pages 519-526Publisher
WILEY
DOI: 10.1111/apa.16189
Keywords
antibiotic susceptibility; early-onset sepsis; late-onset sepsis; neonatal intensive care unit; neonatal sepsis
Categories
Ask authors/readers for more resources
The study found that early-onset sepsis was mainly caused by group B streptococci, Escherichia coli, and Staphylococcus aureus, all of which were susceptible to empiric ampicillin and gentamicin. Late-onset sepsis was mainly caused by coagulase-negative staphylococci, Staphylococcus aureus, and Enterococci, which were sensitive to vancomycin and cefotaxime.
Aim This observational study investigated the microbiology of blood culture-positive sepsis episodes and susceptibility to empiric antibiotics in early-onset sepsis (EOS) and late-onset sepsis (LOS) in a level-four neonatal intensive care unit (NICU) from 2010 to 2019. Methods It was based on patient records and data that Oslo University Hospital, Norway, routinely submitted to the Norwegian Neonatal Network database. Clinical data were merged with blood culture results, including antibiotic susceptibility. Results We studied 5249 infants admitted to the NICU 6321 times and identified 324 positive blood cultures from 287 infants, with 30 EOS and 305 LOS episodes. Frequent causative agents for EOS were group B streptococci (33.3%), Escherichia coli (20.0%) and Staphylococcus aureus (16.7%). All were susceptible to empiric ampicillin and gentamicin. LOS was most frequently caused by coagulase-negative staphylococci (CONS) (73.8%), Staphylococcus aureus (15.7%) and Enterococci (6.9%). CONS, Staphylococcus aureus, Enterococci, Escherichia coli, Klebsiella and Enterobacter represented 91.9% of LOS episodes and were susceptible to vancomycin and cefotaxime (96.1%), vancomycin and gentamicin (97.0%) and cloxacillin and gentamicin (38.1%). Conclusion Empiric treatment with ampicillin and gentamicin was adequate for EOS. Combining vancomycin and gentamicin may be a safer alternative to cefotaxime for LOS, as this reduces exposure to broad-spectrum antibiotics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available